Clinical Trials Browser

Recruiting × Colorectal Cancer Metastatic × Oxaliplatin × Clear all

NCT05727163 2025-05-30

FOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM Patients

Phase 2 Recruiting

Gastrointestinal

Colorectal Cancer Metastatic

NCT06282445 2025-02-17

Efficacy and Safety of Chemotherapy With XELOX (Oxaliplatin + Capecitabine) and Bevacizumab in Combination With Adebrelimab in First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal Cancer

Phase 2 Recruiting

Gastrointestinal

Colorectal Cancer Metastatic